Рекомендации ESPEN-ESPGHAN-ECFS по диетотерапии при муковисцидозе у младенцев, детей и взрослых

208

Coste TC, Armand M, Lebacq J, Lebecque P, Wallemacq P, Leal T. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis. [234 Clin Biochem 2007;40:511-20

209

Lloyd-Still JD, Bibus DM, Powers CA, Johnson SB, Holman RT. Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis. ActaPaediatr 1996;85:1426-32

210

Alicandro G, Faelli N, Gagliardini R, Santini B, Magazzu G, Biffi A, et al. A randomized placebo-controlled study on high-dose oral algal docosahex- aenoic acid supplementation in children with cystic fibrosis. Prostagl Leukot Essent Fat Acids 2013;88:163-9

211

De Vizia B, Raia V, Spano C, Pavlidis C, Coruzzo A, Alessio M. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. JPEN J Parenter Enteral Nutr 2003;27:52-7

212

Panchaud A, Sauty A, Kernen Y, Decosterd LA, Buclin T, Boulat O, et al. Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial. Clin Nutr 2006;25:418-27

213

De Vizia B, Raia V, Spano C, Pavlidis C, Coruzzo A, Alessio M. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. JPEN J Parenter Enteral Nutr 2003;27:52-7

214

Keen C, Olin AC, Eriksson S, Ekman A, Lindblad A, Basu S, et al. Supplementation with fatty acids influences the airway nitric oxide and inflammatory markers in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2010;50:537-44

215

Bianchi ML, Colombo C, Assael BM, Dubini A, Lombardo M, Quattrucci S, et al. Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate. Lancet Respir Med 2013;1:377-85

216

Stalvey MS, Clines GA. Cystic fibrosis-related bone disease: insights into a growing problem. Curr Opin Endocrinol Diabetes Obes 2013;20:547-52

217

Whyte MP, McAlister WH, Novack DV, Clements KL, Schoenecker PL, Wenkert D. Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases. J Bone Min Res 2008;23:1698-707

218

Hardin DS. A review of the management of two common clinical problems found in patients with cystic fibrosis: cystic fibrosis-related diabetes and poor growth. Horm Res 2007;68(Suppl. 5): 113-6

219

Bianchi ML, Romano G, Saraifoger S, Costantini D, Limonta C, Colombo C. BMD and body composition in children and young patients affected by cystic fibrosis. J Bone Min Res 2006;21:388-96

220

Phung OJ, Coleman CI, Baker EL, Scholle JM, Girotto JE, Makanji SS, et al. Recombinant human growth hormone in the treatment of patients with cystic fibrosis. Pediatrics 2010;126:el211 -26

221

Stalvey MS, Anbar RD, Konstan MW, Jacobs JR, Bakker B, Lippe B, et al. A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis. Pediatr Pulmonol 2012;47:252-63

222

Phung OJ, Coleman CI, Baker EL, Scholle JM, Girotto JE, Makanji SS, et al. Recombinant human growth hormone in the treatment of patients with cystic fibrosis. Pediatrics 2010;126:el211 -26

223

Phung OJ, Coleman CI, Baker EL, Scholle JM, Girotto JE, Makanji SS, et al. Recombinant human growth hormone in the treatment of patients with cystic fibrosis. Pediatrics 2010;126:el211 -26

224

Stalvey MS, Anbar RD, Konstan MW, Jacobs JR, Bakker B, Lippe B, et al. A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis. Pediatr Pulmonol 2012;47:252-63

225

Thaker V, Haagensen AL, Carter B, Fedorowicz Z, Houston BW. Recombinant growth hormone therapy for cystic fibrosis in children and young adults. Cochrane Database Syst Rev 2013;6:CD008901

226

Marchand V, Baker SS, Stark TJ, Baker RD. Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2000;31:264-9

227

Eubanks V, Koppersmith N, Wooldridge N, Clancy JP, Lyrene R, Arani RB, et al. Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis. J Pediatr 2002; 140: 439-44

228

Homnick DN, Homnick BD, Reeves AJ, Marks JH, Pimentel RS, Bonnema SK. Cyproheptadine is an effective appetite stimulant in cystic fibrosis. Pediatr Pulmonol 2004;38:129-34

229

Epifanio M, Marostica PC, Mattiello R, Feix L, Nejedlo R, Fischer GB, et al. A randomized, double-blind, placebo-controlled trial of cyproheptadine for appetite stimulation in cystic fibrosis. J Pediatr (Rio J) 2012;88:155-60

230

Butel MJ. Probiotics, gut microbiota and health. Med Mai Infect 2014;44:1-8

231

Chiu YH, Lin SL, Tsai JJ, Lin MY. Probiotic actions on diseases: implications for therapeutic treatments. Food Funct 2014;5:625-34

232

Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V, et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004;20:813-9

233

Bruzzese E, Raia V, Spagnuolo MI, Volpicelli M, De Marco G, Maiuri L, et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin Nutr 2007;26:322-8

234

Weiss B, BujanoverY, Yahav Y, Vilozni D, Fireman E, Efirati O. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatr Pulmonol 2010;45:536-40

235

Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80

236

Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73

237

Kerem E, Conway S, Elborn S, Heijerman H, Consensus С Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibres 2005;4: 7-26

238

Hammons AJ, Fiese B. Mealtime interactions in families of a child with cystic fibrosis: a meta-analysis. J Cyst Fibres 2010;9:377-84

239

Crist W, McDonnell P, Beck M, Gillespie CT, Barrett P, Mathews J. Behavior at mealtimes and the young child with cystic fibrosis. J Dev Behav Pediatr 1994;15:157-61

240

Duff AJ, Wolfe SP, Dickson C, Conway SP, Brownlee KG. Feeding behavior problems in children with cystic fibrosis in the UK: prevalence and comparison with healthy controls. J Pediatr Gastroenterol Nutr 2003;36:443-7

241

Stark LJ, Jelalian E, Powers SW, Mulvihill MM, Opipari LC, Bowen A, et al. Parent and child mealtime behavior in families of children with cystic fibrosis. J Pediatr 2000;136:195-200

242

Culhane S, George C, Pearo B, Spoede E. Malnutrition in cystic fibrosis: a review. Nutr Clin Pract 2013;28:676-83

243

Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008;108:832-9

244

Engelen MP, Com G, Deutz NEP Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis. Curr Opin Clin Nutr Metab Care 2014;17:515-20

245

Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibres 2002;1:51-75

246

Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008;108:832-9

247

Li L, Somerset S. Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy. Dig Liver Dis 2014;46:865-74

248

EFSA Panel on Dietetic Products Nutrition and Allergies. Scientific opinion on dietary reference values for energy. EFSA J 2013;11. 3005, 112pp

249

Engelen MP, Com G, Deutz NEP Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis. Curr Opin Clin Nutr Metab Care 2014;17:515-20

250

Engelen MP, Com G, Deutz NEP Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis. Curr Opin Clin Nutr Metab Care 2014;17:515-20

251

Gaskin KJ. Nutritional care in children with cystic fibrosis: are our patients becoming better? Eur J Clin Nutr 2013;67:558-64

252

Matel JL. Nutritional management of cystic fibrosis. JPEN J Parenter Enteral Nutr 2012;36:60S-7S

253

Strandvik B. Fatty acid metabolism in cystic fibrosis. Prostagl Leukot Essent Fat Acids 2010;83:121-9

254

Smith C, Winn A, Seddon P, Ranganathan S. A fat lot of good: balance and trends in fat intake in children with cystic fibrosis. J Cyst Fibres 2012;11: 154-7

255

Woestenenk JW, Castelijns SJ, van derEnt CK, Houwen RH. Dietary intake in children and adolescents with cystic fibrosis. Clin Nutr 2014;33:528-32

256

Engelen MP, Com G, Deutz NEP Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis. Curr Opin Clin Nutr Metab Care 2014;17:515-20

257

Engelen MP, Com G, Deutz NEP Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis. Curr Opin Clin Nutr Metab Care 2014;17:515-20

258

Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008;108:832-9

259

Engelen MP, Com G, Deutz NEP Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis. Curr Opin Clin Nutr Metab Care 2014;17:515-20

260

Arvanitakis SN, Lobeck CC. Metabolic alkalosis and salt depletion in cystic fibrosis. J Pediatr 1973;82:535-6

261

Kalnins D, Wilschanski M. Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies. Drug Des Devel Ther 2012;6: 151-61

262

Sermet-Gaudelus I, Mayell SJ, Southern KW, European Cystic Fibrosis Society NSWG Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening. J Cyst Fibres 2010;9:323-9

263

Cystic Fibrosis Foundation, Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009; 155:S73-93

264

Sermet-Gaudelus I, Mayell SJ, Southern KW, European Cystic Fibrosis Society NSWG Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening. J Cyst Fibres 2010;9:323-9

265

Coates AJ, Crofton PM, Marshall T. Evaluation of salt supplementation in CF infants. J Cyst Fibres 2009;8:382-5

266

Ozcelik U, Gocmen A, Kiper N, Coskun T, Yilmaz E, Ozguc M. Sodium chloride deficiency in cystic fibrosis patients. Eur J Pediatr 1994;153:829-31

267

Ozcelik U, Gocmen A, Kiper N, Coskun T, Yilmaz E, Ozguc M. Sodium chloride deficiency in cystic fibrosis patients. Eur J Pediatr 1994;153:829-31

268

Commission Directive 2006/141/EC of22 December 2006 on infant formulae and follow-on formulae and amending Directive 1999/21/EC Text with EEA relevance. Off J Eur Union 2006. L 401/1

269

Cystic Fibrosis Foundation, Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009; 155:S73-93

270

Cystic Fibrosis Trust. Nutritional management of cystic fibrosis. Bromley, UK: Cystic Fibrosis Trust; 2002

271

Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibres 2002;1:51-75

272

Cystic Fibrosis Foundation, Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009; 155:S73-93

273

Sermet-Gaudelus I, Mayell SJ, Southern KW, European Cystic Fibrosis Society NSWG Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening. J Cyst Fibres 2010;9:323-9

274

Kalnins D, Wilschanski M. Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies. Drug Des Devel Ther 2012;6: 151-61

275

Coates AJ, Crofton PM, Marshall T. Evaluation of salt supplementation in CF infants. J Cyst Fibres 2009;8:382-5

276

Meuller D. Medical nutrition therapy for pulmonary disease. In: Mahan L, Escort-Stump S, Raymond J. editors. Krause's food and the nutrition care process. St Louis, MO: Elsevier Saunders; 2012. p. 782–98

277

Coates AJ, Crofton PM, Marshall T. Evaluation of salt supplementation in CF infants. J Cyst Fibres 2009;8:382-5

278

Cystic Fibrosis Trust. Bone Mineralisation Working Group, Bone mineralisation in cystic fibrosis. Bromley, UK: Cystic Fibrosis Trust; 2007

279

Sermet-Gaudelus I, Bianchi ML, Garabedian M, Aris RM, Morton A, Hardin DS, et al. European cystic fibrosis bone mineralisation guidelines. J Cyst Fibres 2011;10(Suppl. 2):S16-23

280

Sermet-Gaudelus I, Bianchi ML, Garabedian M, Aris RM, Morton A, Hardin DS, et al. European cystic fibrosis bone mineralisation guidelines. J Cyst Fibres 2011;10(Suppl. 2):S16-23

281

Cystic Fibrosis Trust. Bone Mineralisation Working Group, Bone mineralisation in cystic fibrosis. Bromley, UK: Cystic Fibrosis Trust; 2007

282

Cheng S, Lyytikainen A, Kroger H, Lamberg-Allardt C, Alen M, Koistinen A, et al. Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial. Am J Clin Nutr 2005;82:1115-26. quiz 1147-1118

283

Sermet-Gaudelus I, Bianchi ML, Garabedian M, Aris RM, Morton A, Hardin DS, et al. European cystic fibrosis bone mineralisation guidelines. J Cyst Fibres 2011;10(Suppl. 2):S16-23

284

Cheng S, Lyytikainen A, Kroger H, Lamberg-Allardt C, Alen M, Koistinen A, et al. Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial. Am J Clin Nutr 2005;82:1115-26. quiz 1147-1118

285

Uijterschout L, Nuij sink M, Hendriks D, Vos R, Brus F. Iron deficiency occurs frequently in children with cystic fibrosis. Pediatr Pulmonol 2014;49:458-62.

286

Gifford AH, Miller SD, Jackson BP, Hampton TH, O'Toole GA, Stanton BA, et al. Iron and CF-related anemia: expanding clinical and biochemical relationships. Pediatr Pulmonol 2011;46:160-5

287

Gifford AH, Miller SD, Jackson BP, Hampton TH, O'Toole GA, Stanton BA, et al. Iron and CF-related anemia: expanding clinical and biochemical relationships. Pediatr Pulmonol 2011;46:160-5

288

Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002;35:246-59

289

von Drygalski A, Biller J. Anemia in cystic fibrosis: incidence, mechanisms, and association with pulmonary function and vitamin deficiency. Nutr Clin Pract 2008;23:557-63

290

Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002;35:246-59

291

Berry AJ. Pancreatic enzyme replacement therapy during pancreatic insufficiency. Nutr Clin Pract 2014;29:312-21

292

Uijterschout L, Swinkels DW, Akkermans MD, Zandstra T, Nuij sink M, Hendriks D, et al. The value of soluble transferrin receptor and hepcidin in the assessment of iron status in children with cystic fibrosis. J Cyst Fibres 2014;13:639-44

293

Fischer R, Simmerlein R, Huber RM, Schiffl H, Lang SM. Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis. Pediatr Pulmonol 2007;42:1193-7

294

von Drygalski A, Biller J. Anemia in cystic fibrosis: incidence, mechanisms, and association with pulmonary function and vitamin deficiency. Nutr Clin Pract 2008;23:557-63

295

Weiss G, Goodnough LT Anemia of chronic disease. N Engl J Med 2005;352: 1011 -23

296

Akanli L, Lowenthal DB, Gjonaj S, Dozor AJ. Plasma and red blood cell zinc in cystic fibrosis. Pediatr Pulmonol 2003;35:2-7

297

Maqbool A, Schall JI, Zemel BS, Garcia-Espana JF, Stallings VA. Plasma zinc and growth status in preadolescent children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2006;43:95-101

298

Neve J, Van Geffel R, Hanocq M, Molle L. Plasma and erythrocyte zinc, copper and selenium in cystic fibrosis. Acta Paediatr Scand 1983;72:437-40

299

Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibres 2002;1:51-75

300

Van Biervliet S, Van Biervliet J-P, Robberecht E, Taylor С Importance of zinc in cystic fibrosis patients. Curr Pediatr Rev 2009;5:184-8

301

Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibres 2002;1:51-75

302

Cystic Fibrosis Foundation, Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009; 155:S73-93

303

Shamseer L, Adams D, Brown N, Johnson JA, Vohra S. Antioxidant micronutrients for lung disease in cystic fibrosis. Cochrane Database Syst Rev 2010:CD007020

304

Winklhofer-Roob BM, Tiran B, Tuchschmid PE, van'tHof MA, Shmerling DH. Effects of pancreatic enzyme preparations on erythrocyte glutathione peroxidase activities and plasma selenium concentrations in cystic fibrosis. Free Radic Biol Med 1998;25:242-9

305

Cystic Fibrosis Foundation, Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009; 155:S73-93

306

Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibres 2002;1:51-75

307

Gallagher M. Intake: the nutrients and their metabolism. In: Mahan L, Escort- Stump S, Raymond J, editors. Krause's food and the nutrition care process. St Louis, MO: Elsevier Saunders; 2012. p. 32–128

308

Dodge JA, Turck D. Cystic fibrosis: nutritional consequences and management. Best Pract Res Clin Gastroenterol 2006;20:531-46

309

Dorlochter L, Aksnes L, Fluge G Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway. EurJ Nutr 2002;41:148-52

310

Maqbool A, Stallings VA. Update on fat-soluble vitamins in cystic fibrosis. Curr Opin Pulm Med 2008;14:574-81

311

Carr SB, Dinwiddie R. Annual review or continuous assessment? J R Soc Med 1996;89 (Suppl. 27):3-7

312

Feranchak AP, Sontag MK, Wagener JS, Hammond KB, Accurso FJ, Sokol RJ. Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr 1999;135:601-10

313

Brei C, Simon A, Krawinkel MB, Naehrlich L. Individualized vitamin A supplementation for patients with cystic fibrosis. Clin Nutr 2013;32:805-10

314

Lancellotti L, D'Orazio C, Mastella G, Mazzi G. Lippi U. Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation. Eur J Pediatr 1996;155:281-5

315

Hakim F, Kerem E, Rivlin J, Bentur L, Stankiewicz H, Bdolach-Abram T, et al. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2007;45:347-53

316

Cameron C, Lodes MW, Gershan WM. Facial nerve palsy associated with a low serum vitamin A level in an infant with cystic fibrosis. J Cyst Fibres 2007;6:241-3

317

Ansari EA, Sahni K, Etherington C, Morton A. Conway SP, Moya E, et al. Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements. BrJ Ophthalmol 1999;83:688-91

318

Lancellotti L, D'Orazio C, Mastella G, Mazzi G. Lippi U. Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation. Eur J Pediatr 1996;155:281-5

319

Scientific Committee on Food. Tolerable upper intake levels for vitamins and minerals. European Food Safety Authority; 2006

320

Ansari EA, Sahni K, Etherington C, Morton A. Conway SP, Moya E, et al. Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements. BrJ Ophthalmol 1999;83:688-91

321

Lindblad A, Diczfalusy U, Hultcrantz R, Thorell A, Strandvik B. Vitamin A concentration in the liver decreases with age in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1997;24:264-70

322

Brei C, Simon A, Krawinkel MB, Naehrlich L. Individualized vitamin A supplementation for patients with cystic fibrosis. Clin Nutr 2013;32:805-10

323

Maqbool A, Stallings VA. Update on fat-soluble vitamins in cystic fibrosis. Curr Opin Pulm Med 2008;14:574-81